Ads
related to: astrazeneca oncology r&d careersEmployment.org has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Baselga was born on 3 July 1959, in Barcelona in Spain. [5] He received his M.D. and Ph.D. degrees from the Autonomous University of Barcelona in 1982. [6] He completed a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center in New York, and subsequently stayed on as a faculty member of its Breast Medicine Service.
The AstraZeneca R&D facility in Mölndal near Gothenburg, Sweden The new AstraZeneca Corporate HQ under construction in Cambridge, United Kingdom AstraZeneca develops, manufactures and sells pharmaceutical and biotechnology products to treat disorders in the oncology , cardiovascular , gastrointestinal , infection , neuroscience , respiratory ...
Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases.
The consolidation of AstraZeneca's global R&D footprint will have an impact on sites in the United States. ... oncology and infectious disease. AstraZeneca operates in over 100 countries and its ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
He was appointed President of R&D at the American Pharma Wyeth 2008. Dolsten joined Pfizer in 2009 during the acquisition of Wyeth as Head of BioTherapeutics . He became Pfizer's Chief Scientific Officer and President of R&D on 26 May 2010, replacing Martin Mackay , who moved to the UK as head of research for AstraZeneca.
In 2013, the company formed a partnership with AstraZeneca to develop treatments for cardiovascular, metabolic, and renal diseases, as well as cancer. Moderna was also awarded a $25,000,000 grant by DARPA through a program Autonomous Diagnostics to Enable Prevention and Therapeutics: Prophylactic Options to Environmental and Contagious Threats ...
Biotech and pharmaceutical companies in the New York metropolitan area represent a significant and growing economic component of the New York metropolitan area, [1] [2] the most populous combined statistical area in the United States [3] and one of the most populous megacities in the world.
Ads
related to: astrazeneca oncology r&d careersEmployment.org has been visited by 100K+ users in the past month